Efloxate

Efloxate
Clinical data
ATC code	C01DX13 (WHO) ;
Identifiers
	IUPAC name ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate;
CAS Number	119-41-5 ;
PubChem CID	8395;
ChemSpider	8089;
UNII	CZU6V3902K;
ChEMBL	ChEMBL1349073;
CompTox Dashboard (EPA)	DTXSID3048736 ;
ECHA InfoCard	100.003.929
Chemical and physical data
Formula	C19H16O5
Molar mass	324.332 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3;
	InChI InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3; Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N;
	(verify)

Efloxate is a vasodilator.^[1]

References

↑ Tomasi AM, Masoni A (August 1977). "[Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris]". La Clinica Terapeutica (in Italian). 82 (3): 227–41. PMID 334448.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

v t e Vasodilators used in cardiac diseases (C01D)
Nitrovasodilators	Nitroglycerin # Isosorbide dinitrate # Isosorbide mononitrate Itramin tosilate Linsidomine Molsidomine Nicorandil Pentaerythritol tetranitrate Propatylnitrate Tenitramine Trolnitrate
Quinolone vasodilators	Flosequinan^‡
Others	Benziodarone Carbocromen Cinepazet Cloridarol Dilazep Efloxate Etafenone Gapicomine Heptaminol Hexobendine Imolamine Levosimendan Nesiritide Nicorandil Oxyfedrine Pimobendan Prenylamine Serelaxin Trapidil Vericiguat
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III